Skip to content

Evaluation of the Neural Therapy Effect on Long Term Postoperative Discomforts in Patients Who Undergo Bilateral Tubal Ligation

Evaluation of the Neural Therapy Effect on Long Term Postoperative Discomforts and Gynecologic Symptoms in Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03761862
Enrollment
113
Registered
2018-12-03
Start date
2016-01-01
Completion date
2018-12-01
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea, Dyspareunia, Neural Therapy of Huneke, Pain, Postoperative, Sterilization, Tubal

Brief summary

The aim of this study was to explore the effect of neural therapy on postoperative pain and discomfort such as abdominal swelling; and gynecologic symptoms such as dysmenorrhea, dyspareunia, amount of menstrual bleeding and vaginitis. It also aimed to find out any possible links between the clinical changes and pathophysiologic mechanisms. One hundred and thirteen patients were randomly divided into two groups (neural therapy and control). Postoperative first day, neural therapy was applied to the T10 to S4 dermatomes and utero-vaginal ganglion in random with local anesthetic agent. All patients were recalled one year after the treatment. The visual analog scale (VAS) were noted in both groups, also discomfort and gynecologic symptoms are recorded.

Interventions

Neural therapy is a form of alternative medicine in which local anesthetic is injected into certain locations of the body in an attempt to treat chronic pain and illness.

Sponsors

Kanuni Sultan Suleyman Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Patients who undergo bilateral tubal ligation

Exclusion criteria

* Previous abdominal surgery * Patients with diseases that could have neurologic complications (DM, SLE ...)

Design outcomes

Primary

MeasureTime frameDescription
Pain scores1 year laterVisual Analog Scale was used as the pain scale.1 to 10 points are given here. High score (8- 10) indicates severe pain.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026